3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
19
Myelodysplastic Syndromes
7
Leukemia, Hairy Cell
4
Leukemia, Biphenotypic, Acute
4
Recurrence
3
Leukemia
3
Sarcoma, Myeloid
2
Leukemia, Myelomonocytic, Chronic
2
Leukemia, Monocytic, Acute
2
Blast Crisis
2
Targeted Therapy
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Neoplasm, Residual
1
Myeloproliferative Disorders
1
Myasthenia Gravis
1
Leukemia, Prolymphocytic, T-Cell
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Interventions
Cyclophosphamide
12
Biopsy
10
Specimen Handling
9
Whole-Body Irradiation
7
Magnetic Resonance Spectroscopy
7
pembrolizumab
6
Peripheral Blood Stem Cell Transplantation
6
Melphalan
6
Etoposide
6
fludarabine
5
duvelisib
5
Brentuximab Vedotin
5
ruxolitinib
4
fludarabine phosphate
4
Vincristine
4
Prednisone
4
Doxorubicin
4
Cytarabine
4
10-propargyl-10-deazaaminopterin
4
romidepsin
3
X-Rays
3
Mycophenolic Acid
3
Immunoglobulin G
3
Granulocyte Colony-Stimulating Factor
3
Gemcitabine
3
Disulfides
3
Carmustine
3
venetoclax
2
tazemetostat
2
sodium-iodide symporter
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lymphoma, T-Cell
×
Cladribine
×
1 year
×
Clear all
No trials found.